Xiao-I Corporation Partners with Leading Bank to Revolutionize Knowledge Management with Advanced AI Technology
SHANGHAI, May 24, 2024 /PRNewswire/ — Xiao-I Corporation (NASDAQ: AIXI) (“Xiao-I” or the “Company”), a leading AI company announces an important partnership with a major Chinese banking institution to enhance its knowledge management. This partnership is expected to rev
NewSound Hearing Aid Celebrates 20th Anniversary
XIAMEN, China, May 24, 2024 /PRNewswire/ — On May 12, 2024, NewSound Hearing Aids commemorated two decades of groundbreaking work with a special anniversary event themed “New Sound Along the Way.” It included the grand opening of the new NewSound Innovation Showcase room, a seminar
61st ERA Congress: Semaglutide significantly reduces risk of major kidney disease events, cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease, groundbreaking study reveals
STOCKHOLM, May 24, 2024 /PRNewswire/ — A pioneering study, presented today at the 61st ERA Congress, has demonstrated that semaglutide significantly reduces the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients with type 2 diabetes and chronic ki
AbelZeta Announces Publication of Abstract for ASCO 2024 Annual Meeting
ROCKVILLE, Md., May 24, 2024 /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta” or the “Company”), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, today announced tha
Alma Unveils Alma Harmony™ and Alma IQ™ in U.S. Market, Advancing Personalization in Aesthetic Treatments
The next generation of the world’s most versatile aesthetic workstation, alongside an intelligent skin analysis system, elevates the patient experience. CHICAGO, May 24, 2024 /PRNewswire/ — Alma, a global leader in energy-based medical and aesthetic solutions, announced the commercial de
HI-Bio Presents Positive Interim Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at 61st European Renal Association (ERA) Congress
Patients receiving nine-dose regimen over five months experienced deep and durable reduction in proteinuria, reaching up to ~50% mean reduction in UPCR at end of study at month 24 and over 18 months after last dose Patients across treatment arms exhibited stabilization in eGFR through 24 months, whi
Titans of Tech: GP Bullhound releases its annual report on the European tech ecosystem
LONDON, May 24, 2024 /PRNewswire/ — Titans of Tech: Unrivalled era of A.I. led innovation for European Tech – No more excuses. GP Bullhound is proud to announce the release of its Titans of Tech 2024 report. For the tenth year in a row, GP Bullhound has released its annual Titans of
Unlocking the Next Level: Esteemed fashion leaders assemble in Copenhagen to catalyse and accelerate sustainability progress
COPENHAGEN, Denmark, May 24, 2024 /PRNewswire/ — On 21-23 May, Global Fashion Summit: Copenhagen Edition 2024 assembled over 1000 esteemed representatives from brands, retailers, NGOs, policy, manufacturers, and innovators from both the fashion and adjacent industries to unlock the next leve
Rokid AR Lite: The first AR glasses powered by Snapdragon® 6 Gen 1 mobile platform
REDWOOD CITY, Calif., May 24, 2024 /PRNewswire/ — Rokid has announced the launch of its new AR device, the Rokid AR Lite, on Kickstarter, marking the first AR glasses powered by the Snapdragon® 6 Gen 1 Mobile Platform. This integration brings the power and versatility of a mid-range smartph
